{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:34:47Z","timestamp":1790310887767,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00330-020-06784-y","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T02:02:25Z","timestamp":1587607345000},"page":"5021-5028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma"],"prefix":"10.1007","volume":"30","author":[{"given":"Alison","family":"Dormieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mezquita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Henry","family":"Cournede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Remon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melodie","family":"Tazdait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Virginia","family":"Bluthgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambros","family":"Tselikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Aboubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Naltet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernelle","family":"Lavaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Gazzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Le Pechoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lassau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Balleyguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Planchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Caramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"issue":"6","key":"6784_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"6784_CR2","unstructured":"INCA - Les cancers en France [Internet]. [cited 2019 Mar 27]. Available from: https:\/\/www.e-cancer.fr\/ressources\/cancers_en_france\/"},{"key":"6784_CR3","doi-asserted-by":"crossref","unstructured":"Locher C, Debieuvre D, Co\u00ebtmeur D et al (2013) Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies. Lung Cancer 81(1):32\u201338","DOI":"10.1016\/j.lungcan.2013.03.001"},{"key":"6784_CR4","unstructured":"Cancer of the Lung and Bronchus - Cancer Stat Facts [Internet]. SEER. [cited 2019 Aug 22]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/lungb.html"},{"key":"6784_CR5","doi-asserted-by":"crossref","unstructured":"Barlesi F, Mazieres J, Merlio J-P et al (2016) Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet 387(10026):1415\u20131426","DOI":"10.1016\/S0140-6736(16)00004-0"},{"key":"6784_CR6","doi-asserted-by":"crossref","unstructured":"Peters S, Camidge DR, Shaw AT et al (2017) Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer. N Engl J Med 377(9):829\u2013838","DOI":"10.1056\/NEJMoa1704795"},{"key":"6784_CR7","unstructured":"Soria J-C, Ohe Y, Vansteenkiste J et al (2018) Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med 378(2):113\u2013125"},{"key":"6784_CR8","doi-asserted-by":"crossref","unstructured":"Zou J, Lv T, Zhu S et al (2017) Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I\/II lung adenocarcinoma. Thorac Cancer 8(3):260\u2013270","DOI":"10.1111\/1759-7714.12436"},{"key":"6784_CR9","doi-asserted-by":"crossref","unstructured":"Liu Y, Kim J, Qu F et al (2016) CT features associated with epidermal growth factor receptor mutation status in patients with lung adenocarcinoma. Radiology. 280(1):271\u2013280","DOI":"10.1148\/radiol.2016151455"},{"issue":"12","key":"6784_CR10","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/JTO.0b013e3181c4dedb","volume":"4","author":"B Solomon","year":"2009","unstructured":"Solomon B, Varella-Garcia M, Camidge DR (2009) ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer. J Thorac Oncol 4(12):1450\u20131454","journal-title":"J Thorac Oncol"},{"key":"6784_CR11","doi-asserted-by":"crossref","unstructured":"Planchard D, Popat S, Kerr K et al (2018) Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Supplement_4):iv192\u2013iv237","DOI":"10.1093\/annonc\/mdy275"},{"key":"6784_CR12","doi-asserted-by":"crossref","unstructured":"Zugazagoitia J, Ramos I, Trigo JM et al (2019) Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping. Ann Oncol 30(2):290\u2013296","DOI":"10.1093\/annonc\/mdy512"},{"key":"6784_CR13","doi-asserted-by":"crossref","unstructured":"Li H, Cao J, Zhang X et al (2017) Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China. Clin Exp Metastasis 34(1):63\u201371","DOI":"10.1007\/s10585-016-9822-x"},{"key":"6784_CR14","doi-asserted-by":"crossref","unstructured":"Kuijpers CCHJ, Hendriks LEL, Derks JL et al (2018) Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer. Lung Cancer 121:76\u201381","DOI":"10.1016\/j.lungcan.2018.05.006"},{"key":"6784_CR15","doi-asserted-by":"crossref","unstructured":"Goldstraw P, Chansky K, Crowley J et al (2016) The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11(1):39\u201351","DOI":"10.1016\/j.jtho.2015.09.009"},{"key":"6784_CR16","unstructured":"Wu S-G, Gow C-H, Yu C-J et al (2008) Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma. Eur Respir J 32(4):924\u2013930"},{"key":"6784_CR17","doi-asserted-by":"crossref","unstructured":"Smits AJJ, Kummer JA, Hinrichs JWJ et al (2012) EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma. Cell Oncol (Dordr) 35(3):189\u2013196","DOI":"10.1007\/s13402-012-0078-4"},{"key":"6784_CR18","doi-asserted-by":"crossref","unstructured":"Zhao J, Dinkel J, Warth A et al (2017) CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation. PLoS One 12(9):e0182741","DOI":"10.1371\/journal.pone.0182741"},{"key":"6784_CR19","doi-asserted-by":"crossref","unstructured":"Sekine A, Kato T, Hagiwara E et al (2012) Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features. Lung Cancer 77(1):64\u201369","DOI":"10.1016\/j.lungcan.2011.12.017"},{"issue":"2","key":"6784_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11060-017-2590-x","volume":"135","author":"M Ge","year":"2017","unstructured":"Ge M, Zhuang Y, Zhou X, Huang R, Liang X, Zhan Q (2017) High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases. J Neurooncol 135(2):413\u2013418","journal-title":"J Neurooncol"},{"key":"6784_CR21","doi-asserted-by":"crossref","unstructured":"Matsumoto S, Takahashi K, Iwakawa R et al (2006) Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int J Cancer 119(6):1491\u20131494","DOI":"10.1002\/ijc.21940"},{"key":"6784_CR22","doi-asserted-by":"crossref","unstructured":"Fujimoto D, Ueda H, Shimizu R et al (2014) Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis. Clin Exp Metastasis. 31(5):543\u2013551","DOI":"10.1007\/s10585-014-9648-3"},{"issue":"2","key":"6784_CR23","first-page":"195","volume":"9","author":"D-Y Shin","year":"2014","unstructured":"Shin D-Y, Na II, Kim CH, Park S, Baek H, Yang SH (2014) EGFR mutation and brain metastasis in pulmonary adenocarcinomas. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 9(2):195\u2013199","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer."},{"key":"6784_CR24","doi-asserted-by":"crossref","unstructured":"Tomasini P, Serdjebi C, Khobta N et al (2016) EGFR and KRAS mutations predict the incidence and outcome of brain metastases in non-small cell lung cancer. Int J Mol Sci 18:17(12)","DOI":"10.3390\/ijms17122132"},{"key":"6784_CR25","doi-asserted-by":"crossref","unstructured":"Han G, Bi J, Tan W et al (2016) A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis? Oncotarget. 7(35):56998\u201357010","DOI":"10.18632\/oncotarget.10933"},{"key":"6784_CR26","doi-asserted-by":"crossref","unstructured":"Renaud S, Seitlinger J, Falcoz P-E et al (2016) Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery. Br J Cancer 115(3):346\u2013353","DOI":"10.1038\/bjc.2016.182"},{"key":"6784_CR27","doi-asserted-by":"crossref","unstructured":"Hasegawa M, Sakai F, Ishikawa R (2016) CT features of epidermal growth factor receptor\u2013mutated adenocarcinoma of the lung: comparison with nonmutated adenocarcinoma. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 11(6):819\u2013826","DOI":"10.1016\/j.jtho.2016.02.010"},{"key":"6784_CR28","doi-asserted-by":"crossref","unstructured":"Lv J, Zhang H, Ma J et al (2018) Comparison of CT radiogenomic and clinical characteristics between EGFR and KRAS mutations in lung adenocarcinomas. Clin Radiol 73(6):590.e1\u2013590.e8","DOI":"10.1016\/j.crad.2018.01.009"},{"key":"6784_CR29","doi-asserted-by":"crossref","unstructured":"Togashi Y, Masago K, Kubo T et al (2011) Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma. Cancer. 117(4):819\u2013825","DOI":"10.1002\/cncr.25618"},{"issue":"8","key":"6784_CR30","doi-asserted-by":"publisher","first-page":"e0161081","DOI":"10.1371\/journal.pone.0161081","volume":"11","author":"J Park","year":"2016","unstructured":"Park J, Kobayashi Y, Urayama KY, Yamaura H, Yatabe Y, Hida T (2016) Imaging characteristics of driver mutations in EGFR, KRAS, and ALK among treatment-na\u00efve patients with advanced lung adenocarcinoma. PLoS One 11(8):e0161081","journal-title":"PLoS One"},{"key":"6784_CR31","doi-asserted-by":"crossref","unstructured":"Doebele RC, Lu X, Sumey C et al (2012) Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer. Cancer. 118(18):4502\u20134511","DOI":"10.1002\/cncr.27409"},{"issue":"1","key":"6784_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1148\/radiol.14140848","volume":"275","author":"C-M Choi","year":"2015","unstructured":"Choi C-M, Kim MY, Hwang HJ, Lee JB, Kim WS (2015) Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation. Radiology. 275(1):272\u2013279","journal-title":"Radiology."},{"issue":"2","key":"6784_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.14740\/wjon1092w","volume":"9","author":"M Mufti","year":"2018","unstructured":"Mufti M, Ching S, Farjami S, Shahangian S, Sobnosky S (2018) A case series of two patients presenting with pericardial effusion as first manifestation of non-small cell lung cancer with BRAF mutation and expression of PD-L1. World J Oncol 9(2):56\u201361","journal-title":"World J Oncol"},{"key":"6784_CR34","doi-asserted-by":"crossref","unstructured":"Gautschi O, Pauli C, Strobel K et al (2012) A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib. J Thorac Oncol 7(10):e23\u2013e24","DOI":"10.1097\/JTO.0b013e3182629903"},{"key":"6784_CR35","doi-asserted-by":"crossref","unstructured":"Rizzo S, Petrella F, Buscarino V et al (2016) CT Radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer. Eur Radiol 26(1):32\u201342","DOI":"10.1007\/s00330-015-3814-0"},{"key":"6784_CR36","doi-asserted-by":"crossref","unstructured":"Mazi\u00e8res J, Peters S, Lepage B et al (2013) Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives. J Clin Oncol Off J Am Soc Clin Oncol 31(16):1997\u20132003","DOI":"10.1200\/JCO.2012.45.6095"},{"key":"6784_CR37","doi-asserted-by":"crossref","unstructured":"Lohinai Z, Klikovits T, Moldvay J, Ostoros G, Raso E, Timar J et al (2017) KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis. Sci Rep 7:39721","DOI":"10.1038\/srep39721"},{"key":"6784_CR38","doi-asserted-by":"crossref","unstructured":"Miao Y, Zhu S, Li H et al (2017) Comparison of clinical and radiological characteristics between anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in treatment na\u00efve advanced lung adenocarcinoma. J Thorac Dis 9(10):3927\u20133937","DOI":"10.21037\/jtd.2017.08.134"},{"key":"6784_CR39","doi-asserted-by":"crossref","unstructured":"Hendriks LEL, Smit EF, Vosse BAH et al (2014) EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? Lung Cancer 84(1):86\u201391","DOI":"10.1016\/j.lungcan.2014.01.006"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-06784-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-020-06784-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-06784-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T23:35:36Z","timestamp":1619134536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-020-06784-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["6784"],"URL":"https:\/\/doi.org\/10.1007\/s00330-020-06784-y","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"26 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Dr. Caroline Caramella.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study because of the retrospective design.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 Prospective\u2022 Observational\u2022 Performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}